D

Doxa AB
STO:DOXA

Watchlist Manager
Doxa AB
STO:DOXA
Watchlist
Price: 1.056 SEK 1.15% Market Closed
Market Cap: 1.4B SEK
Have any thoughts about
Doxa AB?
Write Note

Doxa AB
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Doxa AB
Cash & Cash Equivalents Peer Comparison

Comparables:
O
OSSD
XVIVO
BACTI B
V
VIMIAN
S
S2M

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
D
Doxa AB
STO:DOXA
Cash & Cash Equivalents
kr11.8m
CAGR 3-Years
121%
CAGR 5-Years
3%
CAGR 10-Years
10%
O
OssDsign AB
STO:OSSD
Cash & Cash Equivalents
kr165.9m
CAGR 3-Years
50%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Cash & Cash Equivalents
kr450m
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
23%
Bactiguard Holding AB
STO:BACTI B
Cash & Cash Equivalents
kr123.2m
CAGR 3-Years
132%
CAGR 5-Years
131%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Cash & Cash Equivalents
€41.2m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Cash & Cash Equivalents
kr1.4m
CAGR 3-Years
-48%
CAGR 5-Years
-45%
CAGR 10-Years
N/A

See Also

What is Doxa AB's Cash & Cash Equivalents?
Cash & Cash Equivalents
11.8m SEK

Based on the financial report for Jun 30, 2024, Doxa AB's Cash & Cash Equivalents amounts to 11.8m SEK.

What is Doxa AB's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
10%

Over the last year, the Cash & Cash Equivalents growth was -92%. The average annual Cash & Cash Equivalents growth rates for Doxa AB have been 121% over the past three years , 3% over the past five years , and 10% over the past ten years .

Back to Top